Wierenga Wendell

Wierenga Wendell is listed in filings as Director at Cytokinetics, Incorporated - Common Stock. This profile follows SEC Form 4 activity through May 27, 2026, including sale activity. Recent filings connect the profile to Cytokinetics, Incorporated - Common Stock (CYTK). The current snapshot covers public activity from Oct 21, 2025 to May 27, 2026. Reported amounts are shown as $331.8K to $50.0K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.